Comparison of a toxin neutralization assay and ELISA for determination of pertussis toxin antibodies

Serodiagnosis and Immunotherapy in Infectious Disease

Volumn 8, Issue 3-4, 1997, Pages 163-167

  Isacson, Jerker ^a   Trollfors, Birger ^a   Lagergård, Teresa ^b   Taranger, John ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

CHO cell; Correlation; ELISA; Neutralization assay; Pertussis toxin

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY; PERTUSSIS TOXIN; PERTUSSIS VACCINE;

ANTIBODY TITER; ARTICLE; CHO CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; PERTUSSIS; PRIORITY JOURNAL;

EID: 0030888661     PISSN: 08880786     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0888-0786(96)01072-4     Document Type: Article

References (26)

1. [1] Butler J, Feldbush T, McGivern P, Stewart N. The enzyme-linked immunosorbent assay (ELISA): a measure of antibody concentration or affinity? Immunochemistry 1978; 15: 131-6
2. [2] Engvall E, Perlmann P. Enzyme-linked immunosorbent assay, ELISA. III. Quantitation of specific antibodies by enzyme-labelled anti-immunoglobulin in antigen-coated tubes. J Immunol 1972; 109: 129-35
3. [3] Manclark C, Meade B, Burstyn D. Serological response to Bordetella pertussis. In: Rose N, Friedman H, Fahey J, eds. Manual of clinical laboratory immunology. Washington, DC: American Society for Microbiology, 1986; 388-94
4. [4] Melville-Smith ME, Seagroatt VA, Watkins JT. A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera. J Biol Stand 1983; 11: 137-44
5. [5] Melville-Smith ME, Balfour A. Estimation of Corynebacterium diphteriae in human sera: a comparison of an enzyme-linked immunosorbent assay with the toxin neutralisation test. J Med Microbiol 1988; 25: 279-83
6. [6] Gillenius P, Jäätmaa E, Askelöf P, Granström M, Tiru M. The standardization of an assay for pertussis toxin and antitoxin in microplate culture of Chinese hamster ovary cells. J Biol Stand 1985; 13: 61-6
7. [7] Lagergård T, Trollfors B, Claesson BA, Karlberg J, Taranger J. Determination of neutralizing antibodies and specific immunoglobulin isotype levels in infants after vaccination against diphteria. Eur J Clin Microbiol Infect Dis 1992; 11: 341-5
8. [8] Isacson J, Trollfors B, Taranger J, Macdowall I, Johansson J, Lagergård T, Robbins JB. Safety, immunogenicity and an open, retrospective study of efficacy of a monocomponent pertussis toxoid vaccine in infants. Pediatr Infect Dis J 1994; 13: 22-7
9. [9] Taranger J, Trollfors B, Lagergård T, Isacson J, Lowe C, Robbins J. Immunogenicity of a new triple toxoid vaccine against diphteria, tetanus and pertussis. Abstract book, IMM 38, First European Paediatric Congress, Paris, 1994
10. [10] Sekura RD, Zhang Y-L, Roberson R, Acton B, Trollfors B, Tolson N, Shiloach J, Bryla D, Muir-Nash J, Koeller D, Schneerson R, Robbins JB. Clinical, metabolic, and antibody responses of adult volunteers to an investigational vaccine composed of pertussis toxin inactivated by hydrogen peroxide. J Pediatr 1988; 113: 806-13
11. [11] Zackrisson G, Lagergård T, Lönnroth I. An enzyme-linked immunosorbent assay method for detection of immunoglobulins to pertussis toxin. Acta Pathol Microbiol Immunol Scand 1986; 94: 227-31
12. [12] Möllby R, Gadler H, Möllby H, Hallander H. Serological analysis in the pertussis vaccine trial. In: A clinical trial of acellular pertussis vaccines in Sweden, Technical Report. Stockholm, Sweden: National Bacteriological Laboratory, 1988
13. [13] Hewlett E, Sauer K, Myers G, Cowell J, Guerrant R. Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin. Infect Immun 1983; 40: 1198-203
14. [14] Trollfors B, Krantz I, Sigurs N, Taranger J, Zackrisson G, Roberson R. Toxin-neutralizing antibodies in patients with pertussis, as determined by an assay using Chinese hamster ovary cells. J Infect Dis 1988; 158: 991-5
15. [15] Ipsen J. Circulating antitoxin at onset of diphteria in 425 patients. J Immunol 1946; 54: 325-47
16. [16] Christenson B, Böttiger M. Epidemiology and immunity to tetanus in Sweden. Scand J Infect Dis 1987; 19: 429-35
17. [17] Simonsen O, Bentzon M, Heron I. ELISA for the routine determination of antitoxin immunity to tetanus. J Biol Stand 1986; 14: 231-9
18. [18] Knight P, Tilleray J, Queminet J. Studies on the correlation of a range of immunoassays for diphteria antitoxin with the guinea-pig intradermal test. Dev Biol Stand 1986; 64: 25-32
19. [19] Simonsen O, Schou C, Heron I. Modification of the ELISA for the estimation of tetanus antitoxin in human sera. J Biol Stand 1987; 15: 143-57
20. [20] Ad Hoc Group for the Study of Pertussis Vaccines. Placebo controlled trial of two acellular pertussis vaccines in Sweden: protective efficacy and adverse events. Lancet 1988; 955-60
21. [21] Granström M, Olinder-Nielsen AM, Holmblad P, Mark A, Hanngren K. Specific immunoglobulin for treatment of whooping cough. Lancet 1991; 338: 1230-3
22. [22] Granström M, Granström G. Serological correlates in whooping cough. Vaccine 1993; 11: 445-8
23. [23] Zackrisson G, Taranger J, Trollfors B. History of whooping cough in nonvaccinated Swedish children, related to serum antibodies to pertussis toxin and filamentous hemagglutinin. J Pediatr 1990; 116: 190-4
24. [24] Ichimaru T, Ohara Y, Hojo M, Miyazaki S, Harano K, Totoki T. Treatment of severe pertussis by administration of specific gamma globulin with high titers anti-toxin antibody. Acta Paediatr 1993; 82: 1076-8
25. [25] Meade BD, Lynn F, Reed GF, Mink CM, Romani TA, Deforest A, Deloria MA. Relationships between functional assays and enzyme immunoassays as measurements of responses to acellular and whole-cell pertussis vaccines. Pediatrics 1995; 96: 595-600
26. [26] Krantz I, Sekura R, Trollfors B, Taranger J, Zackrisson G, Lagergård T, Schneerson R, Robbins J. Immunogenicity and safety of a pertussis vaccine composed of pertussis toxin inactivated by hydrogen peroxide, in 18-to 23-month-old children. J Pediatr 1990; 116: 539-43